Maxigen Biotech Inc. (TPE:1783)
42.40
+0.90 (2.17%)
Mar 10, 2026, 9:39 AM CST
-15.54% (1Y)
| Market Cap | 3.35B |
| Revenue (ttm) | 792.49M |
| Net Income (ttm) | 234.07M |
| Shares Out | 80.69M |
| EPS (ttm) | 2.59 |
| PE Ratio | 16.02 |
| Forward PE | n/a |
| Dividend | 0.83 (1.93%) |
| Ex-Dividend Date | Sep 5, 2025 |
| Volume | 19,159 |
| Average Volume | 96,990 |
| Open | 41.80 |
| Previous Close | 41.50 |
| Day's Range | 41.80 - 42.45 |
| 52-Week Range | 35.55 - 50.70 |
| Beta | 0.29 |
| RSI | 29.88 |
| Earnings Date | Mar 20, 2026 |